ATTO SCHEDULE 13G: SEC filing

venBio Global Strategic Fund IV, L.P. and its general partner

Filed with the SEC on · accession 0000905148-26-004977

ATTO filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. venBio Global Strategic Fund IV, L.P. and its general partner filed a Schedule 13G reporting beneficial ownership of 4,181,366 shares, or approximately 9.2%, of Attovia Therapeutics common stock as of September 30, 2026. The stock moved -2.7% by the first close after the filing.

Summary of the filing

venBio Global Strategic Fund IV, L.P. and its general partner filed a Schedule 13G reporting beneficial ownership of 4,181,366 shares, or approximately 9.2%, of Attovia Therapeutics common stock as of September 30, 2026. The filing is a passive ownership disclosure under Rule 13d-1(d).

Key details

Shares beneficially owned$4.2M
Percent of class beneficially ownedPCT 9
Total shares outstanding as of September 30, 2026$45.7M
Reporting person / beneficial ownervenBio Global Strategic Fund IV, L.P.
General partner of the reporting fundvenBio Global Strategic GP IV, LLC
IssuerAttovia Therapeutics, Inc.
Member of general partner ivAaron Royston
Member of general partner ivCorey Goodman
Member of general partner ivRichard Gaster
Attorney-in-factDavid Pezeshki

How ATTO stock reacted

Close before

$15.13

Nov 13, 2026

First close after

-2.71%

$14.72

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ATTO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ATTO?

Click here

Frequently asked questions

What did ATTO file with the SEC on Nov 16, 2026?

ATTO filed a SCHEDULE 13G (SEC filing). venBio Global Strategic Fund IV, L.P. and its general partner filed a Schedule 13G reporting beneficial ownership of 4,181,366 shares, or approximately 9.2%, of Attovia Therapeutics common stock as of September 30, 2026. The filing is a passive ownership disclosure under Rule 13d-1(d).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did ATTO stock react to this filing?

ATTO closed at $15.13 before the filing and $14.72 on Nov 16, 2026 (-2.71%).

Other ATTO SEC filings

Get alerts when ATTO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days